Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07214142 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

Study acronym: TNT-Immunity
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Research Objective:To investigate the efficacy and safety of the "total neoadjuvant chemoradiotherapy combined with immunotherapy" regimen for the treatment of locally advanced rectal cancer with high-risk features for recurrence. Study Design:A single-arm, multicenter clinical study. Study Population: Patients with locally advanced rectal cancer presenting with high-risk features for local recurrence.
Trial Details
NCT Number NCT07214142
Lead Sponsor The First Affiliated Hospital of University of Science and Technology of China
Conditions
(from sponsor)		 Rectal Cancer Patients
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov